Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

Investing.com -- U.S. pharmaceutical company Eli Lilly (NYSE: LLY) has introduced its diabetes and weight-loss drug Mounjaro ...

At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles ...

Primarily aimed to help manage type 2 diabetes better, Mounjaro is a wonder drug associated with weight loss, something similar to Ozempic.

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

New FDA rules will end some Long Islanders' access to low-cost alternatives to the pricey weight-loss drugs Zepbound and ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Here is a link to watch the earliest episodes of Donald Trump’s mid-aughts reality show, “The Apprentice,” now streaming on ...

Iowa Attorney General Brenna Bird Friday, March 7 announced a multistate letter urging the Food and Drug Administration to take immediate action to stop the surge in dangerous, counterfeit weight ...